Telesis Bio, Inc. (NASDAQ:TBIO) shares are moving higher on Thursday after the company announced a partnership with Beckman Coulter Life Sciences.

The partnership integrates Telesis Bio's Gibson SOLA Enzymatic Synthesis technology with the Biomek Echo One System from Beckman Coulter Life Sciences.

"By integrating Gibson SOLA's high-fidelity, scalable, and non-toxic DNA synthesis capabilities with Beckman Coulter Life Sciences automation expertise, we are setting a new standard for on-premises biofoundries", said Eric Esser, CEO of Telesis Bio.

How To Buy Telesis Bio Shares

By now you're likely curious about how to participate in the market for Telesis Bio (NASDAQ:TBIO) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

TBIO Price Action: At the time of writing, Telesis stock is trading 41.4% higher at $3.28, according to data from Benzinga Pro.

Image: Photo via Shutterstock